Inactivated HMPV A Antigen

  • Check with publisher
  • Published date: February 25, 2019
    • Shirley, New York, United States

Human metapneumovirus (HMPV) is a member of the Paramyxoviridae virus family. It is a negative-sense single-stranded RNA and is closely related to the avian metapneumovirus (AMPV) subgroup C. Infection in the upper respiratory tract is associated with mild illness, while lower respiratory tract infection can cause fever, cough, pneumonia, bronchiolitis and wheezing. Severe lower respiratory tract infection is most common in the very young, the very old and the immunosuppressed. The peak age of hospitalization for infants with HMPV occurs between 6–12 months of age, slightly older than the peak of RSV, which is around 2–3 months. The clinical features and severity of HMPV are similar to those of RSV. HMPV is also an important cause of disease in older adults. https://www.creative-biolabs.com/vaccine/inactivated-hmpv-a-antigen-306.htm

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 6th Annual Next Generation Sequencing USA Congress

    6th Annual Next Generation Sequencing USA Congress

    Life Sciences Boston (Massachusetts) November 28, 2019 Check with publisher

    350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together ...

  • 5th Annual Advances in Immuno-Oncology Congress

    5th Annual Advances in Immuno-Oncology Congress

    Life Sciences London (London) November 12, 2019 Check with publisher

    Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools. Over 60 presentations, case studies and p...

  • 7th Annual Peptides & Oligonucleotides Congress

    7th Annual Peptides & Oligonucleotides Congress

    Life Sciences London (United Kingdom) November 6, 2019 Check with publisher

    Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. Over 40 case studies, presentations and panel discussions foc...